Sam Harris
Associate, Investor Relations
Sam supports investor engagement and fundraising at Oxford Science Enterprises, working across both OSE and its portfolio companies to strengthen relationships with shareholders and co-investors globally.
He joined in 2024 with experience in capital raising and venture building, having founded and led SmashMedicine – a neuroscience-based digital education platform. Earlier, Sam managed pan-European tech projects at the University of Oxford’s Department of Oncology and was selected for the Oxford Foundry accelerator.
Sam holds a first-class BSc in Neuroscience from the University of Manchester.
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting spinouts?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.